Beamtree Holdings (ASX: BMT) is an Australian-listed company in the Healthcare sector with a market capitalisation of $27.6M and the 1189th-largest security on the ASX by market capitalisation. The BMT share price is $0.095, down 4.04% today and down 71.25% over the past 12 months. Shares have traded between $0.08 and $0.325 over the past 52 weeks. In its most recent reported period (ending 31 Dec 2025), Beamtree Holdings reported revenue of $14.5M and a net loss of $2.9M.
About Beamtree Holdings Limited
Headquartered in Redfern, Australia, Beamtree Holdings Limited, founded in 1996, develops and markets cutting-edge clinical decision support (CDS) solutions for the healthcare sector, both within Australia and globally. The company offers a diverse range of products aimed at improving operational accuracy and patient outcomes. Among these are RippleDown Expert, providing live patient monitoring and notification capabilities, and RippleDown Auditor, which automates real-time data verification to ensure precision in billing, data entry, and specimen reception while identifying potential errors. Beamtree also offers PICQ, a quality assessment tool for clinically coded data used by public and private hospitals, health services, and state health authorities, alongside RISQ, designed for the measurement, benchmarking, and management of hospital-acquired complications. Further expanding its suite, the Q Coding Platform delivers an end-to-end workflow for clinical coding, grouping, reporting, and auditing, supported by Codexpert, a digital reference application for classification information in patient records. Additionally, the company provides expert advisory and auditing services, such as desktop analysis, data maturity assessments, and physical audits, reaching its clientele through strategic channel partners. The company adopted its current name, Beamtree Holdings Limited, in August 2021, having previously been known as PKS Holdings Limited.
